Literature DB >> 20809255

Liver stem/progenitor cells in the canals of Hering: cellular origin of hepatocellular carcinoma with bile duct tumor thrombi?

Ningfu Peng1, Lequn Li, Xiang Cai, Shaozao Tan, Ting Wu.   

Abstract

It is generally believed that the invasion of hepatocellular carcinoma (HCC) into the biliary tree ultimately leads to the formation of bile duct tumor thrombi (BDTT). However, recent studies revealed that primary tumor might be small, even undetectable, and there was no histopathologic evidence of direct tumor invasion into bile duct wall in some patients. During the last decade, efforts on stem cell biology may shed light on the pathogenesis of BDTT. Presently, accumulating evidence supports the following notions: (1) the canals of Hering (CoH) are the most likely origin of liver stem/progenitor cells (LSPCs) in adult livers; (2) similar signalling pathways may regulate self-renewal in LSPCs and liver cancer cells, and a substantial proportion of liver tumors may often originate from the transformation of LSPCs; and (3) liver cancer contains rare cells with stem cell-like properties, which could derive from malignant transformation of LSPCs. Herein, we propose that HCC with BDTT, especially with small or undetectable primary lesion and/or no histopathologic evidence for bile duct invasion, might arise from LSPCs residing in the CoH and, possibly, some primary lesions are formed firstly within the intrahepatic biliary tree. When "tumor thrombi" extends mainly along bile duct, there might be "BDTT" alone; when it invades into surrounding parenchyma, there might often be small "primary tumor" with "BDTT". If this holds true, the putative type may be a particular subset of HCC, and most importantly it would facilitate our understanding of stem-cell origin of HCC.

Entities:  

Mesh:

Year:  2010        PMID: 20809255     DOI: 10.1007/s12015-010-9188-4

Source DB:  PubMed          Journal:  Stem Cell Rev Rep        ISSN: 2629-3277            Impact factor:   5.739


  59 in total

1.  Icteric type hepatoma.

Authors:  T Y Lin; K M Chen; Y R Chen; W S Lin; T H Wang; J L Sung
Journal:  Med Chir Dig       Date:  1975

2.  Hedgehog signaling maintains resident hepatic progenitors throughout life.

Authors:  Jason K Sicklick; Yin-Xiong Li; Alaa Melhem; Eva Schmelzer; Marzena Zdanowicz; Jiawen Huang; Montserrat Caballero; Jeff H Fair; John W Ludlow; Randall E McClelland; Lola M Reid; Anna Mae Diehl
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2005-12-01       Impact factor: 4.052

3.  Hepatocellular carcinoma with biliary tumor thrombi: aggressive operative approach after appropriate preoperative management.

Authors:  M Shiomi; J Kamiya; M Nagino; K Uesaka; T Sano; N Hayakawa; M Kanai; H Yamamoto; Y Nimura
Journal:  Surgery       Date:  2001-06       Impact factor: 3.982

4.  Identification and characterization of tumorigenic liver cancer stem/progenitor cells.

Authors:  Stephanie Ma; Kwok-Wah Chan; Liang Hu; Terence Kin-Wah Lee; Jana Yim-Hung Wo; Irene Oi-Lin Ng; Bo-Jian Zheng; Xin-Yuan Guan
Journal:  Gastroenterology       Date:  2007-04-15       Impact factor: 22.682

5.  Hepatitis C virus infection as a likely etiology of intrahepatic cholangiocarcinoma.

Authors:  Satoshi Yamamoto; Shoji Kubo; Seikan Hai; Takahiro Uenishi; Takatsugu Yamamoto; Taichi Shuto; Shigekazu Takemura; Hiromu Tanaka; Osamu Yamazaki; Kazuhiro Hirohashi; Takashi Tanaka
Journal:  Cancer Sci       Date:  2004-07       Impact factor: 6.716

6.  Diagnosis and surgical treatments of hepatocellular carcinoma with tumor thrombosis in bile duct: experience of 34 patients.

Authors:  Lun-Xiu Qin; Zeng-Chen Ma; Zhi-Quan Wu; Jia Fan; Xin-Da Zhou; Hui-Chuan Sun; Qing-Hai Ye; Lu Wang; Zhao-You Tang
Journal:  World J Gastroenterol       Date:  2004-05-15       Impact factor: 5.742

7.  Activation of hepatic stem cell marker EpCAM by Wnt-beta-catenin signaling in hepatocellular carcinoma.

Authors:  Taro Yamashita; Anuradha Budhu; Marshonna Forgues; Xin Wei Wang
Journal:  Cancer Res       Date:  2007-11-15       Impact factor: 12.701

8.  Surgery of hepatocellular carcinoma complicated with cancer thrombi in bile duct: efficacy for criteria for different therapy modalities.

Authors:  Luo Xiangji; Tan Weifeng; Yi Bin; Liu Chen; Jiang Xiaoqing; Zhang Baihe; Shen Feng; Wu Mengchao
Journal:  Langenbecks Arch Surg       Date:  2009-05-07       Impact factor: 3.445

9.  Expression and clinical significance of the stem cell marker CD133 in hepatocellular carcinoma.

Authors:  W Song; H Li; K Tao; R Li; Z Song; Q Zhao; F Zhang; K Dou
Journal:  Int J Clin Pract       Date:  2008-05-08       Impact factor: 2.503

10.  EpCAM and alpha-fetoprotein expression defines novel prognostic subtypes of hepatocellular carcinoma.

Authors:  Taro Yamashita; Marshonna Forgues; Wei Wang; Jin Woo Kim; Qinghai Ye; Huliang Jia; Anuradha Budhu; Krista A Zanetti; Yidong Chen; Lun-Xiu Qin; Zhao-You Tang; Xin Wei Wang
Journal:  Cancer Res       Date:  2008-03-01       Impact factor: 12.701

View more
  6 in total

Review 1.  Stages based molecular mechanisms for generating cholangiocytes from liver stem/progenitor cells.

Authors:  Wei-Hui Liu; Li-Na Ren; Tao Chen; Li-Ye Liu; Li-Jun Tang
Journal:  World J Gastroenterol       Date:  2013-11-07       Impact factor: 5.742

2.  Hepatocellular carcinoma presenting as bile duct tumor: a case report.

Authors:  Luca Seriau; Cosimo Alex Leo; Rossano Girometti; Claudio Avellini; Umberto Baccarani; Alessandro Uzzau
Journal:  J Gastrointest Cancer       Date:  2014-12

3.  Tumors with macroscopic bile duct thrombi in non-HCC patients: dynamic multi-phase MSCT findings.

Authors:  Qing-Yu Liu; Xiao-Feng Lin; Hai-Gang Li; Ming Gao; Wei-Dong Zhang
Journal:  World J Gastroenterol       Date:  2012-03-21       Impact factor: 5.742

4.  Clinicopathological characteristics and liver stem cell marker expression in hepatocellular carcinoma involving bile duct tumor thrombi.

Authors:  Ye-Bin Pang; Jian-Hong Zhong; Xiao-Ling Luo; Chao Ou; Zhe Guo; Bang-De Xiang; Ning-Fu Peng; Le-Qun Li
Journal:  Tumour Biol       Date:  2015-11-19

5.  Cancer stem cells in hepatocellular carcinoma--an immunohistochemical study with histopathological association.

Authors:  Smita Mary Matthai; Banumathi Ramakrishna
Journal:  Indian J Med Res       Date:  2015-10       Impact factor: 2.375

6.  Caution for diagnosis and surgical treatment of recurrent cholangitis: lessons from 5 cases of bile duct tumor thrombus without a detectable intrahepatic tumor.

Authors:  Zheng Wu; Kun Guo; Hao Sun; Liang Yu; Yi Lv; Bo Wang
Journal:  Medicine (Baltimore)       Date:  2014-09       Impact factor: 1.889

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.